133 related articles for article (PubMed ID: 30765818)
1. Annual change in FEV
Suzuki M; Makita H; Konno S; Shimizu K; Nasuhara Y; Nagai K; Akiyama Y; Fuke S; Saito H; Igarashi T; Takeyabu K; Nishimura M
Sci Rep; 2019 Feb; 9(1):2073. PubMed ID: 30765818
[TBL] [Abstract][Full Text] [Related]
2. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
[TBL] [Abstract][Full Text] [Related]
3. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
[TBL] [Abstract][Full Text] [Related]
4. Effect of a single exacerbation on decline in lung function in COPD.
Halpin DMG; Decramer M; Celli BR; Mueller A; Metzdorf N; Tashkin DP
Respir Med; 2017 Jul; 128():85-91. PubMed ID: 28610675
[TBL] [Abstract][Full Text] [Related]
5. Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease.
Kim J; Yoon HI; Oh YM; Lim SY; Lee JH; Kim TH; Lee SY; Lee JH; Lee SD; Lee CH
Int J Chron Obstruct Pulmon Dis; 2015; 10():1819-27. PubMed ID: 26379432
[TBL] [Abstract][Full Text] [Related]
6. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.
Nishimura M; Makita H; Nagai K; Konno S; Nasuhara Y; Hasegawa M; Shimizu K; Betsuyaku T; Ito YM; Fuke S; Igarashi T; Akiyama Y; Ogura S;
Am J Respir Crit Care Med; 2012 Jan; 185(1):44-52. PubMed ID: 22016444
[TBL] [Abstract][Full Text] [Related]
7. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
[TBL] [Abstract][Full Text] [Related]
8. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.
Lange P; Celli B; Agustí A; Boje Jensen G; Divo M; Faner R; Guerra S; Marott JL; Martinez FD; Martinez-Camblor P; Meek P; Owen CA; Petersen H; Pinto-Plata V; Schnohr P; Sood A; Soriano JB; Tesfaigzi Y; Vestbo J
N Engl J Med; 2015 Jul; 373(2):111-22. PubMed ID: 26154786
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal decline in lung function: a community-based cohort study in Korea.
Leem AY; Park B; Kim YS; Chang J; Won S; Jung JY
Sci Rep; 2019 Sep; 9(1):13614. PubMed ID: 31541126
[TBL] [Abstract][Full Text] [Related]
10. Decline in FEV
Hiller AM; Piitulainen E; Jehpsson L; Tanash H
Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
[No Abstract] [Full Text] [Related]
11. Longitudinal changes in lung hyperinflation in COPD.
Park J; Lee CH; Lee YJ; Park JS; Cho YJ; Lee JH; Lee CT; Yoon HI
Int J Chron Obstruct Pulmon Dis; 2017; 12():501-508. PubMed ID: 28223790
[TBL] [Abstract][Full Text] [Related]
12. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Kamada T; Kaneko M; Tomioka H
Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
[TBL] [Abstract][Full Text] [Related]
13. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
14. Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis.
Chen W; Sadatsafavi M; FitzGerald JM; Lynd LD; Sin DD
Respir Res; 2021 Feb; 22(1):59. PubMed ID: 33602241
[TBL] [Abstract][Full Text] [Related]
15. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
[TBL] [Abstract][Full Text] [Related]
16. Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients.
Nagai K; Makita H; Suzuki M; Shimizu K; Konno S; Ito YM; Nishimura M;
Int J Chron Obstruct Pulmon Dis; 2015; 10():745-57. PubMed ID: 25914531
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease.
Oda N; Miyahara N; Ichikawa H; Tanimoto Y; Kajimoto K; Sakugawa M; Kawai H; Taniguchi A; Morichika D; Tanimoto M; Kanehiro A; Kiura K
Int J Chron Obstruct Pulmon Dis; 2017; 12():1119-1124. PubMed ID: 28435245
[TBL] [Abstract][Full Text] [Related]
18. Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data.
Lee HY; Choi SM; Lee J; Park YS; Lee CH; Kim DK; Lee SM; Yoon HI; Yim JJ; Kim YW; Han SK; Yoo CG
Int J Chron Obstruct Pulmon Dis; 2015; 10():2185-92. PubMed ID: 26508848
[TBL] [Abstract][Full Text] [Related]
19. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
Wise RA
Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors of Rapid FEV1 Decline in a Real-World Chronic Obstructive Pulmonary Disease Cohort.
Lee HW; Lee JK; Lee MG; Shin KC; Ra SW; Kim TH; Hwang YI; Jung KS; Yoo KH; Kim DK
Respiration; 2022; 101(12):1078-1087. PubMed ID: 36349793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
